Original Research
Published on 26 Sep 2018
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2018.00411
- 8,670 views
- 43 citations
